financetom
Business
financetom
/
Business
/
BRIEF-Aureus Greenway Holdings Inc Files For IPO Of 3 Million Shares Of Our Common Stock- SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Aureus Greenway Holdings Inc Files For IPO Of 3 Million Shares Of Our Common Stock- SEC Filing
Jun 20, 2024 2:30 PM

* AUREUS GREENWAY HOLDINGS INC FILES FOR IPO OF 3 MILLION

SHARES

OF OUR COMMON STOCK- SEC FILING

* AUREUS GREENWAY HOLDINGS INC: ADDITIONAL 750,000 SHARES OF

COMMON STOCK BEING OFFERED BY THE SELLING STOCKHOLDERS

* AUREUS GREENWAY HOLDINGS INC: EXPECT INITIAL PUBLIC

OFFERING

PRICE TO BE IN THE RANGE OF $4.00 TO $6.00 PER SHARE

* AUREUS GREENWAY HOLDINGS: RESERVED SYMBOL "AGH" FOR

PURPOSES OF

LISTING COMMON STOCK ON NASDAQ, HAVE APPLIED TO LIST COMMON

STOCK ON NASDAQ

* AUREUS GREENWAY HOLDINGS: REVERE SECURITIES, LLC IS THE

UNDERWRITER FOR IPO

Source text for Eikon:

Further company coverage: [ ]

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ECARX Names Dylan Jeng as CFO
ECARX Names Dylan Jeng as CFO
Mar 23, 2026
07:51 AM EDT, 03/23/2026 (MT Newswires) -- ECARX ( ECX ) said Monday it has named Dylan Jeng as chief financial officer, effective immediately. Jeng, who will be based in ECARX's ( ECX ) Singapore office, has over two decades of financial leadership experience, the company said. ...
Bausch + Lomb Higher in New York Trading, Reports Positive Elios Trial Results
Bausch + Lomb Higher in New York Trading, Reports Positive Elios Trial Results
Mar 23, 2026
07:52 AM EDT, 03/23/2026 (MT Newswires) -- Bausch + Lomb ( BLCO ) , up 5% in New York trading, Monday announced positive 24-month results from the U.S. clinical trial of the Elios system, which involved 318 patients. Developed to treat elevated intraocular pressure (IOP) in patients with open angle glaucoma, Elios is an implant-free procedure that uses excimer laser...
Nasdaq and Talos Partner for Tokenized Collateral Management
Nasdaq and Talos Partner for Tokenized Collateral Management
Mar 23, 2026
07:53 AM EDT, 03/23/2026 (MT Newswires) -- Nasdaq (NDAQ) said Monday it will connect Talos' digital asset infrastructure with its Calypso and Trade Surveillance platforms to develop an integrated product for managing tokenized collateral. The integration will allow market participants to manage both on-chain and off-chain collateral workflows within an integrated environment and expand institutional connectivity to marketplaces and custodians...
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment
Mar 23, 2026
March 23 (Reuters) - Kali Therapeutics said on Monday it has entered into a licensing agreement with French drugmaker Sanofi to develop the privately held firm's experimental treatment for several autoimmune diseases. Here are the details: * Under the deal, Sanofi will obtain global rights to KT501, a tri-specific antibody utilizing Kali Therapeutics' proprietary discovery and research platform. * Kali...
Copyright 2023-2026 - www.financetom.com All Rights Reserved